Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!
Swiss drugmaker Roche faces the prospect of hiring an outsider to replace its chairman of 16 years after its most suitable board members turned down the job. The 117-year old company - the world's largest maker of cancer drugs - set itself an autumn deadline to find a successor to Franz Humer, an influential, hands-on former Roche chief executive who says he will not stand for re-election next year. But the search hit an early stumbling block when the CEOs of Shell and Nestle, who both sit on Roche's board, said they weren't interested.
Help employers find you! Check out all the jobs and post your resume.
Swiss drugmaker Roche faces the prospect of hiring an outsider to replace its chairman of 16 years after its most suitable board members turned down the job. The 117-year old company - the world's largest maker of cancer drugs - set itself an autumn deadline to find a successor to Franz Humer, an influential, hands-on former Roche chief executive who says he will not stand for re-election next year. But the search hit an early stumbling block when the CEOs of Shell and Nestle, who both sit on Roche's board, said they weren't interested.
Help employers find you! Check out all the jobs and post your resume.
